Scotia Capital Inc. Pfizer Inc Transaction History

Scotia Capital Inc.

$17 Billion
Q2 2024

A detailed history of Scotia Capital Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Scotia Capital Inc. holds 1,077,368 shares of PFE stock, worth $32.1 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,077,368

Previous 1,057,482 1.88%

Holding current value

$32.1 Million

Previous $29.3 Million 2.72%

% of portfolio

0.18%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $502,320 - $588,625	19,886 Added 1.88%	1,077,368 $30.1 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $5.34 Million - $6.13 Million	-206,262 Reduced 16.32%	1,057,482 $29.3 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $9.55 Million - $12.4 Million	-365,560 Reduced 22.44%	1,263,744 $36.4 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $10.2 Million - $11.9 Million	-316,862 Reduced 16.28%	1,629,304 $54 Million
Q2 2023 Aug 03, 2023	SELL	$36.12 - $41.79 $1.86 Million - $2.15 Million	-51,509 Reduced 2.58%	1,946,166 $71.4 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $137,431 - $178,915	3,489 Added 0.17%	1,997,675 $81.5 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $575,774 - $751,609	-13,791 Reduced 0.69%	1,994,186 $102 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $3.99 Million - $4.87 Million	-91,256 Reduced 4.35%	2,007,977 $87.9 Million
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $2.98 Million - $3.53 Million	-64,046 Reduced 2.96%	2,099,233 $110 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $1.05 Million - $1.3 Million	22,925 Added 1.07%	2,163,279 $112 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $1.35 Million - $2 Million	-32,696 Reduced 1.5%	2,140,354 $126 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $13.2 Million - $16.9 Million	-335,973 Reduced 13.39%	2,173,050 $93.5 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $7.95 Million - $9.01 Million	221,386 Added 9.68%	2,509,023 $98.3 Million
Q1 2021 May 06, 2021	BUY	$33.49 - $37.77 $574,018 - $647,377	17,140 Added 0.75%	2,287,637 $82.9 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $7.05 Million - $8.96 Million	210,633 Added 10.23%	2,270,497 $83.6 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $3.92 Million - $4.59 Million	123,342 Added 6.37%	2,059,864 $75.6 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $485,504 - $588,988	16,119 Added 0.84%	1,936,522 $63.5 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $2.83 Million - $4.04 Million	104,696 Added 5.77%	1,920,403 $62.7 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $4.7 Million - $5.33 Million	142,625 Added 8.52%	1,815,707 $71.2 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $4.48 Million - $5.81 Million	137,925 Added 8.98%	1,673,082 $60.1 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $8.02 Million - $9.01 Million	216,987 Added 16.46%	1,535,157 $66.5 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $1.92 Million - $2.11 Million	51,243 Added 4.04%	1,318,170 $56 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $4.54 Million - $5.17 Million	117,906 Added 10.26%	1,266,927 $55.3 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $4 Million - $4.85 Million	-116,028 Reduced 9.17%	1,149,021 $50.6 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $524,711 - $559,395	15,910 Added 1.27%	1,265,049 $44.6 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $113,886 - $132,124	3,569 Added 0.29%	1,249,139 $44.3 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $941,723 - $999,201	28,314 Added 2.33%	1,245,570 $45.1 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $7.18 Million - $7.91 Million	231,697 Added 23.51%	1,217,256 $43.4 Million
Q2 2017 Aug 15, 2017	BUY	N/A	985,559	985,559 $33.1 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Pfizer Inc Transaction History